Wearable Bladder Monitor for Neurogenic Bladder

EP
LC
Overseen ByLysanne Campeau, Ph.D.
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of this pilot feasibility study is to evaluate a wearable microwave (MW)-based bladder monitoring system in adult volunteers and those with spinal cord injury (SCI) who use self-catheterization for bladder management. The study aims to learn whether the device can monitor bladder filling and estimate bladder volume non-invasively.

The main questions the study aims to answer are:

1. Can the MW-based monitoring system distinguish between non-full and full bladder states?

2. How accurately do MW-based bladder volume estimates agree with ultrasound bladder scans and voided urine volumes?

3. Is the wearable monitoring system feasible, comfortable, and usable for individuals with SCI?

Participants will:

1. Complete questionnaires about bladder symptoms and quality of life

2. Wear up to six non-invasive MW sensors on the lower pelvic region

3. Undergo two bladder filling and voiding cycles during the study visit

4. Have MW measurements collected approximately every five minutes during bladder filling

5. Undergo ultrasound bladder scans and bladder volume measurements for comparison

6. Complete a post-study usability and comfort survey

Who Is on the Research Team?

EP

Emily Porter, Ph.D.

Principal Investigator

McGill University

LC

Lysanne Campeau, Ph.D.

Principal Investigator

McGill University

Are You a Good Fit for This Trial?

This trial is for adults, including those with spinal cord injury who manage their bladder using self-catheterization. Participants should be able to complete study procedures and questionnaires. People with conditions that prevent safe participation may not be eligible.

Inclusion Criteria

I can use the toilet on my own.
I am over 18 years old.
No pregnancy
See 2 more

Exclusion Criteria

I cannot stay still while my bladder fills.
I need help using the toilet.
I am under 18 years old.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Study Visit

Participants undergo two bladder filling and voiding cycles with MW measurements

1 day
1 visit (in-person)

Data Analysis

Collected MW measurement data will be analyzed to investigate signal trends and feasibility

1-2 weeks

Follow-up

Participants are monitored for safety and effectiveness after the study visit

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Wearable microwave Bladder Monitoring System

Trial Overview

The study is testing a wearable device that uses microwave sensors placed on the lower abdomen to monitor how full the bladder is. The device's accuracy and comfort are compared to standard ultrasound scans during two cycles of filling and emptying the bladder.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Microwave Bladder Monitoring in Individuals with Spinal Cord InjuryExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

McGill University Health Centre/Research Institute of the McGill University Health Centre

Lead Sponsor

Trials
476
Recruited
170,000+

Congressionally Directed Medical Research Programs

Collaborator

Trials
59
Recruited
10,600+